Mediclin AG
XETRA:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XETRA:MED
Watchlist
Price: 2.56 EUR -1.54% Market Closed
Market Cap: 121.6m EUR
Have any thoughts about
Mediclin AG?
Write Note

Intrinsic Value

The intrinsic value of one MED stock under the Base Case scenario is 20.28 EUR. Compared to the current market price of 2.56 EUR, Mediclin AG is Undervalued by 87%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MED Intrinsic Value
20.28 EUR
Undervaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Mediclin AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MED?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Mediclin AG

Provide an overview of the primary business activities
of Mediclin AG.

What unique competitive advantages
does Mediclin AG hold over its rivals?

What risks and challenges
does Mediclin AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mediclin AG.

Provide P/S
for Mediclin AG.

Provide P/E
for Mediclin AG.

Provide P/OCF
for Mediclin AG.

Provide P/FCFE
for Mediclin AG.

Provide P/B
for Mediclin AG.

Provide EV/S
for Mediclin AG.

Provide EV/GP
for Mediclin AG.

Provide EV/EBITDA
for Mediclin AG.

Provide EV/EBIT
for Mediclin AG.

Provide EV/OCF
for Mediclin AG.

Provide EV/FCFF
for Mediclin AG.

Provide EV/IC
for Mediclin AG.

Show me price targets
for Mediclin AG made by professional analysts.

What are the Revenue projections
for Mediclin AG?

How accurate were the past Revenue estimates
for Mediclin AG?

What are the Net Income projections
for Mediclin AG?

How accurate were the past Net Income estimates
for Mediclin AG?

What are the EPS projections
for Mediclin AG?

How accurate were the past EPS estimates
for Mediclin AG?

What are the EBIT projections
for Mediclin AG?

How accurate were the past EBIT estimates
for Mediclin AG?

Compare the revenue forecasts
for Mediclin AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mediclin AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mediclin AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mediclin AG compared to its peers.

Compare the P/E ratios
of Mediclin AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Mediclin AG with its peers.

Analyze the financial leverage
of Mediclin AG compared to its main competitors.

Show all profitability ratios
for Mediclin AG.

Provide ROE
for Mediclin AG.

Provide ROA
for Mediclin AG.

Provide ROIC
for Mediclin AG.

Provide ROCE
for Mediclin AG.

Provide Gross Margin
for Mediclin AG.

Provide Operating Margin
for Mediclin AG.

Provide Net Margin
for Mediclin AG.

Provide FCF Margin
for Mediclin AG.

Show all solvency ratios
for Mediclin AG.

Provide D/E Ratio
for Mediclin AG.

Provide D/A Ratio
for Mediclin AG.

Provide Interest Coverage Ratio
for Mediclin AG.

Provide Altman Z-Score Ratio
for Mediclin AG.

Provide Quick Ratio
for Mediclin AG.

Provide Current Ratio
for Mediclin AG.

Provide Cash Ratio
for Mediclin AG.

What is the historical Revenue growth
over the last 5 years for Mediclin AG?

What is the historical Net Income growth
over the last 5 years for Mediclin AG?

What is the current Free Cash Flow
of Mediclin AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mediclin AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mediclin AG

Current Assets 319.3m
Cash & Short-Term Investments 193.2m
Receivables 113.3m
Other Current Assets 12.8m
Non-Current Assets 584.8m
Long-Term Investments 60.9k
PP&E 518.2m
Intangibles 22.1m
Other Non-Current Assets 44.4m
Current Liabilities 183.8m
Accounts Payable 9.5m
Other Current Liabilities 174.3m
Non-Current Liabilities 508m
Long-Term Debt 424.3m
Other Non-Current Liabilities 83.7m
Efficiency

Earnings Waterfall
Mediclin AG

Revenue
771.1m EUR
Cost of Revenue
-129.6m EUR
Gross Profit
641.5m EUR
Operating Expenses
-623.7m EUR
Operating Income
17.8m EUR
Other Expenses
-29m EUR
Net Income
-11.2m EUR

Free Cash Flow Analysis
Mediclin AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Mediclin AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROIC is Increasing
Positive 3-Years Revenue Growth
49/100
Profitability
Score

Mediclin AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
33/100
Solvency
Score

Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Mediclin AG

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 4.36 EUR with a low forecast of 3.84 EUR and a high forecast of 4.99 EUR.

Lowest
Price Target
3.84 EUR
50% Upside
Average
Price Target
4.36 EUR
70% Upside
Highest
Price Target
4.99 EUR
95% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MED?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Mediclin AG Logo
Mediclin AG

Country

Germany

Industry

Health Care

Market Cap

121.6m EUR

Dividend Yield

0%

Description

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).

Contact

BADEN-WUERTTEMBERG
Offenburg
Okenstr. 27
+497814880.0
www.mediclin.de

IPO

2000-12-04

Employees

7 115

Officers

Chairman of Management Board & CEO
Dr. Joachim Ramming
CFO & Member of the Management Board
Mr. Tino Fritz
COO & Member of Management Board
Mr. Thomas Piefke
Head of Group Accounting
Mr. Mario Waidele
Head of Investor Relations and Sustainability
Ender Gulcan
Head of Law
Ms. Katja Kiesewetter
Show More
Head of Purchasing & Medical Technology
Mr. Jörg Störmer
Head of Payroll & Application Management
Ms. Carin Emminghaus
Head of Quality Medicine & Head of Internal Auditing
Dr. Ralf Bürgy
Head of Finance & Accounting
Mr. Frank Heuberger
Show Less

See Also

Discover More
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 20.28 EUR.

Is MED stock undervalued or overvalued?

Compared to the current market price of 2.56 EUR, Mediclin AG is Undervalued by 87%.

Back to Top